Cerevel Therapeutics Holdings (CERE) director Sulzberger received 10,461 shares
Insider transactions reported
Gabrielle Sulzberger (director at Cerevel Therapeutics Holdings Inc., CERE) reported that they received 10,461 shares on Jun 5, 2024. After these transactions the filing shows 58,876 shares held directly.
- Reporting person
- Sulzberger Gabrielle
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 5, 2024 | Grant or award (A) | Common Stock1 | +10,461 | - | - | 58,876 direct |
Holdings before and after
- Common Stock: 48,415 to 58,876 direct
Footnotes from the filing
- 1. The shares reported in this transaction represent Restricted Stock Units ( RSUs ) granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 100% of the RSUs subject to this grant shall vest upon the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the 2025 annual meeting of stockholders of the Company.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Sulzberger report in this CERE Form 4?
Gabrielle Sulzberger (director at Cerevel Therapeutics Holdings Inc., CERE) reported that they received 10,461 shares on Jun 5, 2024. After these transactions the filing shows 58,876 shares held directly.
How many CERE shares does Sulzberger hold after this filing?
The filing shows 58,876 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for CERE
Earlier insider filings at CERE
- Jun 7, 2024Mckernan Ruth was granted 10,461 shares, increasing direct ownership by 319% to 13,743 units (SEC Form 4)
- Jun 5, 2024Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,030,520 worth of shares (50,000 units at $40.61) (SEC Form 4)
- May 14, 2024Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,105,125 worth of shares (50,000 units at $42.10) (SEC Form 4)
- Apr 3, 2024Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,116,640 worth of shares (50,000 units at $42.33) (SEC Form 4)
- Mar 6, 2024Coles N Anthony exercised 50,000 shares at a strike of $3.50 and sold $2,050,550 worth of shares (50,000 units at $41.01) (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Follow CERE and get a push notification the moment its next story breaks.